Recent Articles

Hantavirus explained: What to know after the cruise ship outbreak

Stay strong at any age with 4 basic exercises

Why testosterone levels drop and when to consider treatment

Don't count on daily aspirin to prevent colon cancer

Night owls' habits linked to worse heart health

After ablation, exercise may lower atrial fibrillation recurrence

What can cause an enlarged heart?

Women's unique risks for heart disease

Chronic kidney disease: A hidden threat to your heart

Navigating your online patient portal: Best practices

For "bad" cholesterol, lower is better; dual drug therapy may help

High cholesterol, in particular high low-density lipoprotein (LDL), the so-called bad cholesterol, is a key cause of heart disease. A large clinical trial called IMPROVE-IT set out in 2005 to answer two key questions about LDL:

How low should drug therapy drive LDL?
Can drugs other than statins, the gold standard for lowering cholesterol, help?

The results of IMPROVE-IT were recently published in The New England Journal of Medicine.

Dr. Deepak L. Bhatt, Editor in Chief of the Harvard Heart Letter, talked about the significance of the IMPROVE-IT findings with Dr. Christopher P. Cannon, the trial's lead investigator, and Dr. John A. Jarcho, an editor of The New England Journal of Medicine.

Print This Page

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.